D-0233-2015 Class II Terminated

Recalled by Actavis Inc — Parsippany, NJ

FDA drug recall D-0233-2015 was initiated by Actavis Inc on Aug 25, 2014 and is designated Class II. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 21, 2018). Affected quantity: 46,676 cartons.

Recall details

Product Type
Drugs
Report Date
Nov 5, 2014
Initiation Date
Aug 25, 2014
Termination Date
Mar 21, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
46,676 cartons

Product description

Vancomycin Hydrochloride Capsule, USP, 250 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3561-15 UPC 3-3-0591356115-1

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide

Code information

3101178, exp Aug 2014, 3104318, exp Aug 2014, 3104319, exp Oct 2014, 3104889, exp Oct 2014, 3104891, exp Oct 2014, 3104893, exp Oct 2014, and 3106651, exp Dec 2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0233-2015
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0233-2015. Report a data issue: hello@regdatalab.com.